WDNA ETF
Wisdomtree BioRevolution Fund

WDNA ETF Overview
WDNA ETF (Wisdomtree BioRevolution Fund) is managed by WisdomTree Investments with $2.2M in net assets. WDNA expense ratio is 0.45%, holding 85 positions across sectors including Health Care, Unknown, Materials. Inception date: 2021-06-01.
WDNA performance shows a YTD return of 8.06%. The 1-year return is 36.70%. WDNA dividend yield stands at 4.20%, paid annually.
WDNA top holdings include Eli Lilly & Co (3.0%), Natera Inc (3.0%), Structure Therapeutics Inc ADR USD.0001 (2.9%), Moderna therapeutics (2.9%), Johnson & Johnson (2.6%). View all WDNA holdings, sector breakdown, or dividend history.
WDNA can be compared against other funds using the overlap calculator or side-by-side comparison tool. WDNA alternatives are available via the screener, along with tax-loss harvesting opportunities.